We are pleased to announce that Cognivia will participate at the Bio International Convention in San Diego, California, from June 22 to June 25, 2026. Where to meet us ? Speaker : More information on : https://convention.bio.org/landing
Topic: signal
Clinical research continues to evolve at an impressive pace. Digital technologies streamline data capture, biomarkers deepen biological insight, and innovative trial designs broaden access for diverse populations. These advances have unquestionably accelerated development and expanded participant reach. Still, across all this progress, one dimension consistently shapes outcomes yet remains underrepresented in planning, modeling, and oversight: patient behavior. Behavioral factors like motivation,
We are pleased to announce that Cognivia will participate in the Fortrea Innovation & Technology Summit in Boston on April 7, 2026. Our CEO, Dominique Demolle, will join the industry panel: “User Experience and Adoption Strategies: Why a Great Product Is Only One Factor in Success.” Speakers: This panel will explore how user experience, adoption
Cognivia is pleased to announce its participation in the OARSI World Congress 2026, taking place in Florida from April 23 to April 26, 2026. During the event, our team will present new findings on placebo response modelling using psychological characteristics in a remote osteoarthritis trial — an approach that strengthens signal detection and improves the
Patient retention or patient engagement have become a main operational challenge in today’s clinical trials. Despite major investments in decentralized models, engagement tools, and site‑facing technology, patient drop‑out still catches clinical operations teams by surprise. And when it does, the impact on timelines, data quality, and site oversight is immediate. A new upcoming webinar from Cognivia
Cognivia launches the world’s first early-warning behavioral risk intelligence dashboard—Cognivia Signal—empowering clinical teams to see what’s coming before it happens. Mont-Saint-Guibert, Belgium – October 9, 2025 – Cognivia, the AI-driven leader in behavioral science for clinical research, proudly announces the launch of Cognivia Signal, a groundbreaking solution designed to transform how clinical trial sponsors manage behavioral risk.